「andmochida pharmaceutical」の検索結果
453件：356～360件目を表示
-
お知らせ | 千寿製薬株式会社
June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（
http://www.senju.co.jp/english/news/ -
千寿製薬株式会社
NEWS & RELEASE June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease throug
http://www.senju.co.jp/english/ -
研究開発の取り組み | 千寿製薬株式会社
R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens
http://www.senju.co.jp/english/rd/ -
点眼剤 (1％、2％) <A> イタリア Carteol S.I.F.I. S.p.A. 1988年 点眼剤 (1％、2％) <B> 香港 Arteoptic Otsuka Pharmaceutical (H.K.) Ltd. 1995 年 点眼剤 (1％、2％) <C> 台湾 Arteoptic TAIWAN OTSUKA PHARMACEUTICAL CO...
https://www.senju.co.jp/system/files/2021-07/20210705_MK_IF.pdf -
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf